Choice of the Optimal Treatment Strategies for Mid-low REctal Cancer

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorPeking Union Medical College Hospital

About this trial

The purpose of this study is to compare the efficacy, prognosis, health economics of different treatment modalities of mid-low rectal cancer in different centers in China, and to conduct cost utility analysis (CUA) on the treatment process of rectal cancer to explore the best treatment modality that meets the actual need of medical units in each region and at each level. The investigators hope to provide evidence-based medical suggestions for medical quality control of rectal cancer and revision of clinical guidelines, and provides a source of decision making for medical management and medical insurance.

Eligibility criteria

Qualifiers

pathologically confirmed rectal adenocarcinoma

located within 12cm below the anal verge

Disqualifiers

diagnosed with distant metastasis

multiple primary colorectal cancers

history of previous malignant tumors

Pregnant or lactating women

Trial design

Treatments tested in this trial

  • Registry study, no specific intervention

Treatment groups

No treatment groups listed